373 EVALUATION OF THE EFFICACY AND SAFETY OF TADALAFIL 20 MG ON DEMAND VS. TADALAFIL 5 MG ONCE-A-DAY IN THE TREATMENT OF ERECTILE DYSFUNCTION FOLLOWING CURATIVE RADIOTHERAPY FOR PROSTATIC CARCINOMA: PRELIMINARY RESULTS OF A RANDOMIZED PHASE II TRIAL

Patrizia Ciammella(Azienda Sanitaria Unità Locale di Reggio Emilia), Francesco Valentino(Sapienza University of Rome), Paolo Gontero(Fondazione Ricerca Molinette), Umberto Ricardi(Azienda Ospedaliero Universitaria San Giovanni Battista), A Tizzani(University of Turin)

European Urology Supplements

March 1, 2009

10.1016/s1569-9056(09)60375-4

Cited by 0

Related Papers

Characterisation and classification of oligometastatic disease: a European Society for Radiotherapy and Oncology and European Organisation for Research and Treatment of Cancer consensus recommendation

|The Lancet Oncology|2020|1.1k

Defining oligometastatic disease from a radiation oncology perspective: An ESTRO-ASTRO consensus document

|Radiotherapy and Oncology|2020|646

EORTC Nomograms and Risk Groups for Predicting Recurrence, Progression, and Disease-specific and Overall Survival in Non–Muscle-invasive Stage Ta–T1 Urothelial Bladder Cancer Patients Treated with 1–3 Years of Maintenance Bacillus Calmette-Guérin

|European Urology|2015|639

An Individual Patient Data Metaanalysis of Outcomes and Prognostic Factors After Treatment of Oligometastatic Non–Small-Cell Lung Cancer

|Clinical Lung Cancer|2014|437

SIOP CNS GCT 96: final report of outcome of a prospective, multinational nonrandomized trial for children and adults with intracranial germinoma, comparing craniospinal irradiation alone with chemotherapy followed by focal primary site irradiation for patients with localized disease

|Neuro-Oncology|2013|371